An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could result in users injecting substances of unknown origin.
Several professionals said the demand for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or prison.
Platform Response and Material Elimination
Based on TikTok, the platform has taken down problematic content and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the service safe and investing in enhancing compliance measures.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or administering at home.
Within moments of joining one community, a vendor posted WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.
Product Information and Pricing
Inside these communities, posts show black plastic packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When asked how long a pen should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A representative for the messaging service stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to potentially serious medical dangers”.
